Related Experiment Video
Updated: May 19, 2026

LERLIC-MS/MS for In-depth Characterization and Quantification of Glutamine and Asparagine Deamidation in Shotgun Proteomics
Published on: April 9, 2017
L-glutamine is a key parameter in the immunosuppression phenomenon
Ines Hammami1, Jingkui Chen, Vincenzo Bronte
1Department of Chemical Engineering, Ecole Polytechnique de Montréal, 2500 Chemin de Polytechnique, Montreal, Quebec, Canada H3T 1J4.
Controlling L-glutamine metabolism in myeloid-derived suppressor cells (MDSCs) could be a new immunotherapy strategy. Limiting L-glutamine impacts inducible nitric oxide synthase (iNOS) activity, crucial for MDSC immunosuppression.
Area of Science:
- Immunology
- Cancer Biology
- Metabolic Research
Background:
- Myeloid-derived suppressor cells (MDSCs) are key regulators of tumor immune evasion.
- MDSCs suppress T-cell functions via enzymes like inducible nitric oxide synthase (iNOS) and arginase (ARG1), which deplete L-arginine.
- Glutaminolysis supports MDSC maturation and function.
Purpose of the Study:
- To investigate the role of L-glutamine (L-Gln) in maintaining the immunosuppressive activity of mouse MDSCs (MSC-1 cell line).
- To understand the metabolic pathways influenced by L-Gln in MDSCs.
Main Methods:
- Culturing MSC-1 cells in L-Gln-limited medium.
- Assessing iNOS and ARG1 activity.
- Evaluating effects on Jukat cell growth and viability.
- Analyzing MSC-1 cell metabolic profiles, including lactate production, NADPH generation, and TCA cycle activity.
Main Results:
- L-Gln limitation inhibited iNOS activity but not ARG1 activity in MSC-1 cells.
- L-Gln is a precursor for lactate production and NADPH via NADP(+)-dependent malic enzyme.
- TCA cycle activity and bioenergetic status were reduced in the absence of L-Gln.
- iNOS activity, unlike ARG1, correlates with enhanced central carbon metabolism and high bioenergetic status.
Conclusions:
- L-glutamine metabolism is critical for maintaining MDSC immunosuppressive function, particularly iNOS activity.
- Targeting glutaminolysis may offer a novel approach for cancer immunotherapy by disrupting MDSC function.
More Related Videos
Related Concept Videos
Inorganic Nitrogen Assimilation
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...

